This study considered MCAM’s potential as a biomarker for mesothelioma as well as a primary receptor for chemotherapy drugs.MCAM may be regarded as more promising than mesothelin because while it has been identified in each subtype of mesothelioma, it is not found in healthy mesothelial cells. In a collection of tissues that included specimens of sarcomatoid, epithelioid and mixed type mesotheliomas, MCAM was identified in more than 80 percent of the total samples. In this study, MCAM was expressed in 28 of 31 epithelioid tissue samples, eight of 10 sarcomatoid samples and 14 of 14 mixed type samples.Mesothelin, on the other hand, is notably absent in sarcomatoid mesothelioma cells. One previous study found mesothelin in 44 of 44 epithelioid mesotheliomas but none of eight sarcomatoid ...
No comments:
Post a Comment